Literature DB >> 29304914

Evaluation and Management of Penicillin Allergy.

Thanai Pongdee1, James T Li2.   

Abstract

Penicillin allergy is the most commonly reported drug allergy in the United States. Although penicillin allergy is widely reported, 80% to 90% of individuals with self-reported penicillin allergy are actually able to tolerate penicillins after undergoing evaluation for penicillin allergy. Because most patients with self-reported penicillin allergy will have subsequent negative allergy testing results and tolerate penicillins, they may be unnecessarily exposed to broader-spectrum antibiotics. Use of such antibiotics leads to increased risks of developing antibiotic-resistant microorganisms and incur higher health care utilization costs. In this article, we provide an overview of penicillin allergy and its clinical manifestations as well as an approach for the evaluation and management of penicillin allergy.
Copyright © 2017 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29304914     DOI: 10.1016/j.mayocp.2017.09.020

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  3 in total

Review 1.  Possible drugs for the treatment of bacterial infections in the future: anti-virulence drugs.

Authors:  Hiroshi Ogawara
Journal:  J Antibiot (Tokyo)       Date:  2020-07-09       Impact factor: 2.649

2.  Adherence to antibiotic guidelines and reported penicillin allergy: pooled cohort data on prescribing and allergy documentation from two English National Health Service (NHS) trusts.

Authors:  Cameron J Phillips; Mark Gilchrist; Fiona J Cooke; Bryony D Franklin; David A Enoch; Michael E Murphy; Reem Santos; Eimear T Brannigan; Alison H Holmes
Journal:  BMJ Open       Date:  2019-03-01       Impact factor: 2.692

3.  Short and long term impact of combining restrictive and enabling interventions to reduce aztreonam consumption in a community hospital.

Authors:  Dviti Mody; Christopher Burke; Quentin Minson
Journal:  Int J Clin Pharm       Date:  2021-03-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.